James E. Bradner, M.D. added as keynote to CHI's Inaugural Chemical Biology for Target Validation

NEEDHAM, Mass. - Feb. 18, 2014 - PRLog -- Genome-Wide Spatial Localization of Small Molecules
James E. Bradner, M.D., Assistant Professor, Department of Medicine, Harvard Medical School and Investigator, Department of Medical Oncology, Dana-Farber Cancer Institute

Other Keynotes include:

Selecting and Modulating Therapeutic Targets Using Human Biology and Chemical Biology
Stuart L. Schreiber, Ph.D., Director, Chemical Biology, Founding Member, Broad Institute of Harvard and MIT; Howard Hughes Medical Institute Investigator; Morris Loeb Professor, Chemistry and Chemical Biology, Harvard University

Structures, Chemical Probes, New Biology, New Targets for Drug Discovery: Is This the Right Sequence?
Chas Bountra, Ph.D., Professor, Translational Medicine; Head, Structural Genomics Consortium, University of Oxford

Covalent Inhibitors of Oncogenic Signaling Pathways
Nathanael Gray, Ph.D., Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; Professor, Cancer Biology, Dana-Farber Cancer Institute

For more information or to register please visit: http://www.healthtech.com/Target-Validation/